nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepenzolate—Loperamide—POMC—adrenal gland cancer	0.549	0.66	CrCbGaD
Mepenzolate—Fexofenadine—ABCB1—adrenal gland cancer	0.103	0.124	CrCbGaD
Mepenzolate—Fentanyl—ABCB1—adrenal gland cancer	0.068	0.0817	CrCbGaD
Mepenzolate—Loperamide—ABCB1—adrenal gland cancer	0.0655	0.0787	CrCbGaD
Mepenzolate—Methadone—ABCB1—adrenal gland cancer	0.0466	0.056	CrCbGaD
Mepenzolate—CHRM1—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.00714	0.0425	CbGpPWpGaD
Mepenzolate—CHRM3—GPCRs, Other—GNRHR—adrenal gland cancer	0.00705	0.042	CbGpPWpGaD
Mepenzolate—CHRM2—GPCRs, Other—GNRHR—adrenal gland cancer	0.00698	0.0416	CbGpPWpGaD
Mepenzolate—CHRM1—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.00477	0.0284	CbGpPWpGaD
Mepenzolate—CHRM3—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.00475	0.0283	CbGpPWpGaD
Mepenzolate—CHRM2—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0047	0.028	CbGpPWpGaD
Mepenzolate—CHRM1—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.00397	0.0237	CbGpPWpGaD
Mepenzolate—CHRM3—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.00396	0.0236	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.00355	0.0212	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.00354	0.0211	CbGpPWpGaD
Mepenzolate—CHRM3—Regulation of insulin secretion—PRKACA—adrenal gland cancer	0.00309	0.0184	CbGpPWpGaD
Mepenzolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00263	0.0157	CbGpPWpGaD
Mepenzolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00262	0.0156	CbGpPWpGaD
Mepenzolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0026	0.0155	CbGpPWpGaD
Mepenzolate—CHRM3—Regulation of insulin secretion—GNAS—adrenal gland cancer	0.0025	0.0149	CbGpPWpGaD
Mepenzolate—CHRM3—Integration of energy metabolism—PRKACA—adrenal gland cancer	0.00243	0.0145	CbGpPWpGaD
Mepenzolate—CHRM1—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00238	0.0142	CbGpPWpGaD
Mepenzolate—CHRM3—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00237	0.0141	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00213	0.0127	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00212	0.0126	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.002	0.0119	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—GNRHR—adrenal gland cancer	0.002	0.0119	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00198	0.0118	CbGpPWpGaD
Mepenzolate—CHRM3—Integration of energy metabolism—GNAS—adrenal gland cancer	0.00197	0.0117	CbGpPWpGaD
Mepenzolate—CHRM1—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00183	0.0109	CbGpPWpGaD
Mepenzolate—CHRM3—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00182	0.0108	CbGpPWpGaD
Mepenzolate—CHRM2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.0018	0.0107	CbGpPWpGaD
Mepenzolate—CHRM2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00174	0.0103	CbGpPWpGaD
Mepenzolate—CHRM1—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00163	0.00972	CbGpPWpGaD
Mepenzolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00158	0.00939	CbGpPWpGaD
Mepenzolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00157	0.00936	CbGpPWpGaD
Mepenzolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00156	0.00927	CbGpPWpGaD
Mepenzolate—CHRM1—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00155	0.00922	CbGpPWpGaD
Mepenzolate—CHRM3—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00154	0.00919	CbGpPWpGaD
Mepenzolate—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00153	0.0091	CbGpPWpGaD
Mepenzolate—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00148	0.00881	CbGpPWpGaD
Mepenzolate—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00148	0.00878	CbGpPWpGaD
Mepenzolate—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00146	0.0087	CbGpPWpGaD
Mepenzolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00141	0.00837	CbGpPWpGaD
Mepenzolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0014	0.00834	CbGpPWpGaD
Mepenzolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00139	0.00826	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0012	0.00715	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0012	0.00713	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00118	0.00706	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00113	0.00674	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00113	0.00672	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00112	0.00666	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00107	0.00637	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—TSHR—adrenal gland cancer	0.00107	0.00635	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00106	0.00629	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00103	0.00612	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00103	0.0061	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00102	0.00604	CbGpPWpGaD
Mepenzolate—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00101	0.00604	CbGpPWpGaD
Mepenzolate—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.000984	0.00586	CbGpPWpGaD
Mepenzolate—CHRM3—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.000981	0.00584	CbGpPWpGaD
Mepenzolate—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.000971	0.00578	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—SDHB—adrenal gland cancer	0.000792	0.00471	CbGpPWpGaD
Mepenzolate—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000683	0.00407	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000678	0.00404	CbGpPWpGaD
Mepenzolate—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000677	0.00403	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000676	0.00403	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00067	0.00399	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.000622	0.00371	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00062	0.00369	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000616	0.00367	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.000614	0.00366	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000614	0.00366	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000608	0.00362	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.000607	0.00362	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—GNRHR—adrenal gland cancer	0.000606	0.00361	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000605	0.0036	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000603	0.00359	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.0006	0.00357	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000597	0.00355	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000565	0.00336	CbGpPWpGaD
Mepenzolate—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.000563	0.00336	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000563	0.00335	CbGpPWpGaD
Mepenzolate—CHRM3—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.000562	0.00334	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000557	0.00332	CbGpPWpGaD
Mepenzolate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.000556	0.00331	CbGpPWpGaD
Mepenzolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00055	0.00328	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.000549	0.00327	CbGpPWpGaD
Mepenzolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000549	0.00327	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—TSHR—adrenal gland cancer	0.000547	0.00326	CbGpPWpGaD
Mepenzolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000543	0.00323	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.000542	0.00323	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000531	0.00316	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000529	0.00315	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000524	0.00312	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—RRM1—adrenal gland cancer	0.00051	0.00304	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—SDHD—adrenal gland cancer	0.00051	0.00304	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00042	0.0025	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.000419	0.0025	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000419	0.00249	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—POMC—adrenal gland cancer	0.000418	0.00249	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.000414	0.00246	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000394	0.00235	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000393	0.00234	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000389	0.00232	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—MED12—adrenal gland cancer	0.00038	0.00227	CbGpPWpGaD
Mepenzolate—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	0.000372	0.00222	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000368	0.00219	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000367	0.00218	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000364	0.00217	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000363	0.00216	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—GNRH1—adrenal gland cancer	0.000363	0.00216	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000359	0.00214	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000352	0.00209	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000351	0.00209	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000347	0.00207	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000334	0.00199	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—CDC42—adrenal gland cancer	0.000333	0.00198	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000333	0.00198	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SPRY2—adrenal gland cancer	0.000332	0.00198	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.00033	0.00196	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000329	0.00196	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.000324	0.00193	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—TSHR—adrenal gland cancer	0.000323	0.00193	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.00032	0.00191	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000319	0.0019	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—GNAS—adrenal gland cancer	0.000318	0.0019	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000315	0.00188	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.000305	0.00182	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MEN1—adrenal gland cancer	0.000304	0.00181	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.000301	0.00179	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PRKACA—adrenal gland cancer	0.000278	0.00165	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000237	0.00141	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000236	0.00141	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000234	0.00139	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000233	0.00139	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000232	0.00138	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.00023	0.00137	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GNAS—adrenal gland cancer	0.000225	0.00134	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—ABCB1—adrenal gland cancer	0.000221	0.00131	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000215	0.00128	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	0.000214	0.00128	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000212	0.00126	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.000197	0.00118	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	0.000197	0.00117	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000195	0.00116	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.00019	0.00113	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	0.00019	0.00113	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.000189	0.00112	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	0.000188	0.00112	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000188	0.00112	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000186	0.00111	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000184	0.0011	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000183	0.00109	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000182	0.00108	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	0.000158	0.000943	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	0.000158	0.00094	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000156	0.000931	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—POMC—adrenal gland cancer	0.000151	0.000902	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	0.000138	0.000821	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	0.000137	0.000818	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000136	0.00081	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	0.000127	0.000756	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	0.000127	0.000754	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.000125	0.000747	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000125	0.000747	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	0.000125	0.000745	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000124	0.000737	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000122	0.000724	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000121	0.000722	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PTGS2—adrenal gland cancer	0.000121	0.000719	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.00012	0.000715	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	9.07e-05	0.00054	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	9.04e-05	0.000538	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	8.95e-05	0.000533	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	7.18e-05	0.000428	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	7.16e-05	0.000426	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	7.09e-05	0.000422	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	6.03e-05	0.000359	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	6.01e-05	0.000358	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	5.95e-05	0.000355	CbGpPWpGaD
